Accriva Diagnostics Hemochron ACT Low Range Test 45/Bx — Grayline Medical

Hemochron 100. Hemochron Signature Elite Coagulation Analyzer The GEM Hemochron 100 is designed for invasive procedures requiring heparin dose adjustment, where rapid and accurate ACT results are essential Leveraging leading Hemochron technology, the GEM Hemochron 100 system, delivers fast, actionable activated clotting time (ACT) results in minutes, informing patient-management decisions and helping improve workflow at the point of care (POC).

ITC Hemochron Signature Elite Whole Blood Microcoagulation system Rapid
ITC Hemochron Signature Elite Whole Blood Microcoagulation system Rapid from medsold.com

180 Hartwell Road Bedford, MA 01730-2443 USA 1-800-955-9525 customerservice.na@werfen.com . Leveraging leading Hemochron technology, the GEM Hemochron 100 system, delivers fast, actionable activated clotting time (ACT) results in minutes, informing patient-management decisions and helping improve workflow at the point of care (POC).

ITC Hemochron Signature Elite Whole Blood Microcoagulation system Rapid

The GEM Hemochron 100 system is currently in clinical use in several European countries and will be commercialized in the US in early 2022 The GEM Hemochron 100 offers the highest level of speed, simplicity, and connectivity in whole blood hemostasis testing, the Werfen press release stated GEMweb Plus 500 Custom Connectivity simplifies and centralizes remote management of POC operators and GEM Hemochron 100 systems, as well as other Werfen and non-Werfen analyzers, throughout a hospital or hospital network..

Hemochron Jr Signature+ Coagulation Analyzer pointofcare. Werfen today announced the 510(k) clearance of the GEM Hemochron 100 whole blood hemostasis system by the US Food and Drug Administration (FDA) The design is aimed for invasive procedures requiring heparin dose adjustment, in cases where ACT results are essential

Coagulation Control Hemochron® Directcheck® Activated Partial. The GEM Hemochron 100 system is currently in clinical use in several European countries and will be commercialized in the US in early 2022 Thank you for downloading the GEM Hemochron 100 brochure! Werfen's GEM Hemochron 100 whole blood hemostasis testing system delivers quality results for monitoring and guiding unfractionated heparin therapy during cardiovascular procedures.